 | Up a level |
2022
Gruell, Henning, Vanshylla, Kanika 
ORCID: 0000-0003-4552-9170, Korenkov, Michael, Tober-Lau, Pinkus, Zehner, Matthias, Munn, Friederike, Janicki, Hanna, Augustin, Max, Schommers, Philipp, Sander, Leif Erik, Kurth, Florian ORCID: 0000-0002-3807-473X, Kreer, Christoph and Klein, Florian ORCID: 0000-0003-1376-1792
(2022).
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns.
Cell Host Microbe, 30 (9).
S. 1231 - 1249.
CAMBRIDGE:
CELL PRESS.
ISSN 1934-6069
Habermann, Elisa ORCID: 0000-0003-1504-4746, Gieselmann, Lutz ORCID: 0000-0003-3699-3318, Tober-Lau, Pinkus ORCID: 0000-0002-9148-3663, Klotsche, Jens, Albach, Fredrik Nils, Ten Hagen, Alexander, Zernicke, Jan, Ahmadov, Elvin, de Silva, Amanthi Nadira Arumahandi, Frommert, Leonie Maria ORCID: 0000-0003-0110-9190, Kurth, Florian ORCID: 0000-0002-3807-473X, Sander, Leif Erik, Burmester, Gerd R., Klein, Florian ORCID: 0000-0003-1376-1792 and Biesen, Robert ORCID: 0000-0002-0434-7832
(2022).
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination.
RMD Open, 8 (2).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2056-5933
Tober-Lau, Pinkus ORCID: 0000-0002-9148-3663, Gruell, Henning, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Koch, Willi M., Hillus, David, Schommers, Philipp, Suarez, Isabelle, Suttorp, Norbert ORCID: 0000-0002-3958-1151, Sander, Leif Erik, Klein, Florian ORCID: 0000-0003-1376-1792 and Kurth, Florian ORCID: 0000-0002-3807-473X
(2022).
Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections.
Emerg. Infect. Dis, 28 (5).
S. 1050 - 1053.
ATLANTA:
CENTERS DISEASE CONTROL & PREVENTION.
ISSN 1080-6059
Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Fan, Chengcheng ORCID: 0000-0003-4213-5758, Wunsch, Marie ORCID: 0000-0002-6570-1831, Poopalasingam, Nareshkumar ORCID: 0000-0002-4981-6209, Meijers, Matthijs ORCID: 0000-0002-1876-8064, Kreer, Christoph ORCID: 0000-0002-9140-9850, Kleipass, Franziska ORCID: 0009-0003-7120-6620, Ruchnewitz, Denis ORCID: 0000-0001-5740-6958, Ercanoglu, Meryem S., Gruell, Henning, Muenn, Friederike, Pohl, Kai, Janicki, Hanna, Nolden, Tobias ORCID: 0000-0002-8996-5612, Bartl, Simone, Stein, Saskia C., Augustin, Max, Dewald, Felix, Gieselmann, Lutz, Schommers, Philipp, Schulz, Thomas F., Sander, Leif Erik, Koch, Manuel ORCID: 0000-0002-2962-7814, Luksza, Marta, Laessig, Michael, Bjorkman, Pamela J. and Klein, Florian ORCID: 0000-0003-1376-1792
(2022).
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers.
Cell Host Microbe, 30 (1).
S. 69 - 94.
CAMBRIDGE:
CELL PRESS.
ISSN 1934-6069
2021
Hillus, David, Schwarz, Tatjana, Tober-Lau, Pinkus, Vanshylla, Kanika, Hastor, Hana ORCID: 0000-0002-8633-1817, Thibeault, Charlotte, Jentzsch, Stefanie, Helbig, Elisa T., Lippert, Lena J., Tscheak, Patricia, Schmidt, Marie Luisa, Riege, Johanna, Solarek, Andre, von Kalle, Christof, Dang-Heine, Chantip, Gruell, Henning, Kopankiewicz, Piotr, Suttorp, Norbert, Drosten, Christian, Bias, Harald, Seybold, Joachim ORCID: 0000-0003-1444-8976, Klein, Florian, Kurth, Florian ORCID: 0000-0002-3807-473X, Corman, Victor Max ORCID: 0000-0002-3605-0136 and Sander, Leif Erik
(2021).
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study.
Lancet Resp. Med., 9 (11).
S. 1255 - 1266.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2213-2600
Tober-Lau, Pinkus, Schwarz, Tatjana, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Hillus, David, Gruell, Henning, Suttorp, Norbert, Landgraf, Irmgard, Kappert, Kai, Seybold, Joachim ORCID: 0000-0003-1444-8976, Drosten, Christian, Klein, Florian, Kurth, Florian ORCID: 0000-0002-3807-473X, Sander, Leif Erik and Corman, Victor Max ORCID: 0000-0002-3605-0136
(2021).
Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers.
Lancet Resp. Med., 9 (11).
S. E104 - 2.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2213-2600